Skip to main content
Caplight Logo









Pulmonx

Pulmonx

Public
Redwood City, CaliforniaHealthcarewww.pulmonx.com

Pulmonx is now publicly traded

The data on this page reflects Pulmonx's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Oct 5, 2020

Last Round

Debt

Feb 1, 2023

Total Funding Raised

$555.2M

Company Overview

Pulmonx (NAS: LUNG) is a medical technology company that offers minimally invasive treatments for severe emphysema, including the Zephyr Endobronchial Valve and associated assessment systems.

Sector

Healthcare

AI Layer

Application

Keywords

endobronchial valve for severe emphysemaminimally invasive emphysema treatmentbronchoscopic lung volume reductionlung hyperinflation reduction devicecollateral ventilation assessment systemnon-surgical alternative to lung surgerycloud-based CT analysis for patient selectionsevere COPD treatment devicesingle-use pulmonology medical devicemedical device for interventional pulmonologyquantitative lung imaging analysis

Pulmonx Comparables

Compare Pulmonx with similar companies based on industry and business-model similarity.

Pulmonx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Apreo Health
76%
Free Flow Medical, Inc.
74%
Nuvaira
72%

Pulmonx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtFeb 1, 2023
IPOOct 5, 2020
Convertible DebtMay 5, 2020
Series GMay 9, 2019
Series F ExtensionJan 1, 2017
Series F
May 1, 2016

Pulmonx Investors

Notable investors and investment history

Pulmonx investors
InvestorRounds
Canaccord GenuityIPO
Ally Bridge GroupConvertible Debt, Series G
MedVenture AssociatesSeries A, Series D, Series C, Series B, Series E
BofA SecuritiesIPO
CIBC Innovation BankingDebt, Convertible Debt
HealthCapSeries D, Series E, Series C
Morgan StanleyIPO

Pulmonx Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pulmonx Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersRedwood City, California
Employee Range285
Year Founded1998
Last FundingFeb 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.